Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors Meeting Abstract
| Authors: | Garcia, V. M.; Calvo, E.; Asch, A.; Butler, M.; Zugazagoitia, J.; Charlson, J.; Cervantes, A.; Van Tine, B.; Aggen, D.; Clarke, J.; Johnson, M.; Wileman, M.; Liddle, A.; Naidoo, R.; Brophy, F.; Rosenberg, M.; Jolliffe, D.; Williams, D.; Norry, E.; Hong, D. |
| Abstract Title: | Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S620 |
| End Page: | S621 |
| Language: | English |
| ACCESSION: | WOS:001087480201349 |
| DOI: | 10.1016/j.annonc.2023.09.2158 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract 1019O -- Source: Wos |
